The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland

@inproceedings{Nagy2016TheCI,
  title={The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland},
  author={Lisa A Nagy and Terho Heikkinen and Alfred Sackeyfio and Richard J Pitman},
  booktitle={PharmacoEconomics},
  year={2016}
}
Trivalent influenza vaccines encompass one influenza B lineage; however, predictions have been unreliable on which of two antigenically distinct circulating lineages will dominate. Quadrivalent seasonal influenza vaccines contain strains from both lineages. This analysis assesses the cost effectiveness of switching from trivalent inactivated influenza vaccination (TIV) in Finland to quadrivalent vaccination, using inactivated (QIV) or live-attenuated (Q-LAIV) vaccines. A transmission model… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
5 Citations
35 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 35 references

Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States

  • K Clements, L McGarry, N Pruttivarasin, DA Misurski, G. Meier
  • Hum Vaccin Immunother
  • 2014
3 Excerpts

Terveyden- ja sosiaalihuollony ksikkökustannukset Suomessavuonna 2011 (Health and social care unit costs in Finland 2011)

  • S Kapiainen, A Vaisanen, T. Haula
  • National Institute for Health and Welfare (THL);
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…